In the latest edition of the professional journal “Science”, Jürgen Knoblich, a leading authority on stem cells and deputy director of the IMBA (Institute for Molecular Biotechnology of the Austrian Academy of Sciences), together with international experts, presents a first ethical guideline for research into human organ models. In the article, he also argues for critical and responsible engagement with the new technology.
Organ models, which are cultivated in the laboratory from human stem cells and grow into living tissue, are one of the most important scientific breakthroughs of recent years. Scientists, patients and the wider public have high hopes for this emerging field of research, as so-called “organoids” have a huge potential in terms of research and modern medicine. In-vitro organ models allow complex organ development studies and pathogenetic analyses to be carried out directly in human tissue. New substances and therapies can be tested on human material much more quickly using this technology. Regenerative medical practice could conceivably cultivate the required tissue in the laboratory from the cells of a patient and, lessen dependency on organ donations. The use of organoids could also significantly reduce the need for animal experiments, although biologists believe these cannot be completely eliminated in the foreseeable future.
Organoids – high hopes and bioethical dilemmas
From an ethical perspective, this new technology raises a whole range of issues. These include important caveats in relation to the use of human embryonic stem cells or the application of gene therapies to prevent or treat diseases. Jürgen Knoblich believes that “the development of organoids is unexplored scientific territory. As a researcher, I am fascinated by the huge potential of this technology. However, I also believe it’s my job to actively promote dialogue around responsible research and to engage the wider public in the discussion”. In 2013, the stem cell specialist made scientific headlines worldwide with his laboratory-cultivated brain models. In the latest policy statement issued in collaboration with the immunologist and geneticist Hans Clevers and the bioethicist and Member of the Dutch Parliament, Annelien Bredenoord, the researchers also examined for the first time the most important ethical dimensions of organoid research. According to Knoblich, “we hope that our work has created a solid foundation for the establishment of framework conditions for responsible engagement with this new technology”.
Receive an email update when we add a new ORGANOIDS article.
The Latest on: Human organ models
via Google News
The Latest on: Human organ models
- The human heart in space: What can we learn from mathematical modelingon October 8, 2020 at 9:38 am
Human spaceflight has been fascinating man for centuries, representing the intangible need to explore the unknown, challenge new frontiers, advance technology and push scientific boundaries further. A ...
- Human heart in space: What can we learn from mathematical modelingon October 8, 2020 at 7:05 am
The research carried out by the Politecnico di Torino shows that space flight ages astronauts' heart Human spaceflight has been fascinating man for centuries, representing the intangible need to ...
- Researchers create p16-Cre ERT2 -tdTomato mouse model to characterize in vivo senescent cellson October 7, 2020 at 5:43 pm
Cell senescence is a state of permanent cell cycle arrest that was initially defined for cells grown in cell culture. It plays a key role in age-associated organ dysfunction and age-related diseases ...
- Remote control of blood sugar: Electromagnetic fields treat diabetes in animal modelson October 6, 2020 at 5:00 pm
Researchers may have discovered a safe new way to manage blood sugar non-invasively. Exposing diabetic mice to a combination of static electric and magnetic fields for a few hours per day normalizes ...
- Javelin Biotech and Pfizer Collaborate To Develop Microphysiological System To Predict Human Pharmacokineticson October 6, 2020 at 12:05 pm
Javelin Biotech and Pfizer have entered a three-year collaboration to design and build a platform to evaluate absorption, distribution, metabolism, and excretion (ADME) properties of small molecules ...
- Why AI can’t ever reach its full potential without a physical bodyon October 5, 2020 at 6:40 am
It would seem that there are no areas that are beyond improvement by AI – no tasks that cannot be automated, no problems that can’t at least be helped by an AI application. But is this strictly true?
- Promising “molecular tweezer” Parkinson’s therapy looks to human trialson October 3, 2020 at 5:00 pm
New research published in the journal Nature Communications reveals a novel drug, designed to break up the aggregations of toxic proteins associated with Parkinson’s disease, can effectively slow the ...
- Experts to Study Human Tissue Models’ Responses to Space Radiation, and Develop Countermeasureson October 2, 2020 at 7:47 am
With an award from the Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine, a partner to the NASA Human Research Program, Sharon Gerecht will lead a team that will ...
- NIH awards grants for using bioengineered models to improve clinical trial designon September 30, 2020 at 5:24 pm
Clinical Trials on a Chip researchers plan to build and test common and rare disease models to help improve the clinical trial process.
via Bing News